Characteristic |
Value (N=133 subjects) |
Gender, n (%) |
|
Male |
47 (35.3) |
Female |
86 (64.7) |
Age (yr), mean (SD) |
60.9 (10.51) |
|
Right Eye (N=133) |
Left Eye (N=132) |
Number of glaucoma medications, n (%) |
|
|
0 |
8 (6.0) |
7 (5.3) |
1 |
102 (76.7) |
103 (78.0) |
2 |
19 (14.3) |
18 (13.7) |
3 |
4 (4.0) |
4 (3.0) |
Glaucoma medication classes, n (%) |
|
|
Beta-blockers |
79 (59.4) |
79 (59.9) |
Prostaglandins |
51 (38.4) |
50 (37.9) |
Carbonic anhydrase inhibitors |
9 (6.8) |
9 (6.8) |
Adrenergic agonists |
10 (7.5) |
10 (7.6) |
Central corneal thickness (μm), mean (SD) |
535.9 (35.9) |
537.5 (46.5) |
Vertical cup-disc ratio, mean (SD) |
0.63 (0.14) |
0.63 (0.13) |
Visual field mean deviation (dB), mean (SD) |
−4.18 (5.14) |
−4.07 (4.24) |
Laser parameters, mean (SD) |
|
|
Total energy (milllijoules) |
82.5 (18.8) |
87.0 (18.5) |
Number of treatment spots |
103.3 (3.5) |
103.1 (3.1) |